{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=208267", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=208267", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=208267&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=208267", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=208267", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=208267", "items" : [{"_about" : "http://data.parliament.uk/resources/1041379", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1041379/answer", "answerText" : {"_value" : "
The landscape of survivor benefits has changed significantly since the publication of the Review, not least because of the Walker judgement. Government will respond to the Review of Survivor Benefits in Occupational Pension Schemes when the assessment of the full implications of the judgement is complete.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4142", "label" : {"_value" : "Biography information for Guy Opperman"} } , "answeringMemberConstituency" : {"_value" : "Hexham"} , "answeringMemberPrinted" : {"_value" : "Guy Opperman"} , "dateOfAnswer" : {"_value" : "2019-01-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-01-17T15:55:08.957Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "29"} , "answeringDeptShortName" : {"_value" : "Work and Pensions"} , "answeringDeptSortName" : {"_value" : "Work and Pensions"} , "date" : {"_value" : "2019-01-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Occupational Pensions Scheme Review"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Work and Pensions, whether the Government has plans to respond to the report entitled, Review of Survivor Benefits in Occupational Pension Schemes, published in June 2014.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"} } , "tablingMemberConstituency" : {"_value" : "Barnsley Central"} , "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"} ], "uin" : "208267"} , {"_about" : "http://data.parliament.uk/resources/90715", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/90715/answer", "answerText" : {"_value" : "
<\/p>
Experiments on animals have been performed over a number of years with the first successful pronuclear transfer (PNT) technique performed in mice in 1983 by McGrath and Solter. Maternal spindle transfer (MST) is a technique developed in the United States of America in 2009 and has been performed successfully in mice, non-human primates, as well as in sheep and cows. Research on both MST and PNT has been carried out successfully on human embryos. On-going studies of PNT and MST continue to be carried out on mice in the United Kingdom.<\/p>
<\/p>
<\/p>
<\/p>
An extensive review of the safety and efficacy of MST and PNT to prevent mitochondrial disease was completed by the Human Fertilisation and Embryology Authority\u2019s Expert Scientific Panel, which includes detailed consideration of animal model studies and can be found on their website:<\/p>
<\/p>
<\/p>
<\/p>
www.hfea.gov.uk/docs/Third_Mitochondrial_replacement_scientific_review.pdf<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-09-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-09-11T14:02:52.9570435Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-09-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Animal Experiments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what estimate he has made of the number of tests on animals conducted in the UK using mitochondrial replacement techniques in each of the last five years; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1437", "label" : {"_value" : "Biography information for Lady Hermon"} } , "tablingMemberConstituency" : {"_value" : "North Down"} , "tablingMemberPrinted" : [{"_value" : "Lady Hermon"} ], "uin" : "208267"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }